Norges Bank
IGMS

Norges Bank’s IGM Biosciences IGMS Stock Holding History

Norges Bank’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-34,463
Closed -$1.01M – 2202
2021
Q4 		$1.01M Hold
34,463
– – ﹤0.01% 2108
2021
Q3 		$2.27M Buy
34,463
+3,530
+11% +$270K ﹤0.01% 2033
2021
Q2 		$2.57M Hold
30,933
– – ﹤0.01% 1986
2021
Q1 		$2.37M Sell
30,933
-22,753
-42% -$2.07M ﹤0.01% 1982
2020
Q4 		$4.74M Hold
53,686
– – ﹤0.01% 1877
2020
Q3 		$3.96M Hold
53,686
– – ﹤0.01% 1902
2020
Q2 		$3.92M Buy
53,686
+32,617
+155% +$1.98M ﹤0.01% 1893
2020
Q1 		$1.18M Buy
21,069
+12,165
+137% +$533K ﹤0.01% 1965
2019
Q4 		$340K Sell
8,904
-1,096
-11% -$27.5K ﹤0.01% 2064
2019
Q3 		$178K Buy
+10,000
New +$202K ﹤0.01% 2081

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Norges Bank's IGMS Position: Q1 2022 in Review

Norges Bank sold out of IGM Biosciences (IGMS) in Q1 2022, closing a stake of 34,463 shares — an estimated $1.01M sold.

Norges Bank first reported a position in IGMS in Q3 2019 and held it in 10 quarters. The position peaked at $4.74M in Q4 2020. 93 funds tracked by Wall St. Rank hold IGMS as of Q1 2022.

  • Norges Bank reported no remaining IGM Biosciences position as of Q1 2022 after selling out during the quarter.
  • Norges Bank sold 34,463 IGM Biosciences shares in Q1 2022, an estimated $1.01M.
  • Norges Bank first reported a position in IGM Biosciences in Q3 2019 and held it in 10 quarters.
  • Norges Bank's IGM Biosciences position peaked at $4.74M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2022.

Based on Norges Bank's 13F filing for Q1 2022, filed 9 May 2022.